Citius Oncology Reports 120% Growth in LYMPHIR Shipments
Preliminary, unaudited fiscal fourth-quarter 2026 sales totaled 792 LYMPHIR units to U.S. wholesalers, up 120% from the prior quarter. Prescribing centers ordered 950 vials, and 54 institutions had ordered LYMPHIR as of October 26.
Citius Oncology reported preliminary, unaudited sales of 792 LYMPHIR units to U.S. wholesalers in fiscal fourth-quarter 2026, up 120% from the prior quarter. Prescribing centers ordered 950 vials during the quarter, and 54 institutions had ordered LYMPHIR as of October 26. The company expects to re…